Back to top

Image: Bigstock

NGM Biopharmaceuticals Shares March Higher, Can It Continue?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor NGM Biopharmaceuticals, Inc. (NGM - Free Report) . The stock has moved higher by 20.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider NGM’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as NGM has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!                  

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. 

Click here for the 6 trades >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


NGM Biopharmaceuticals, Inc. (NGM) - free report >>

Published in